{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:02:18Z","timestamp":1789603338555,"version":"build-2803163510"},"reference-count":98,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","award":["P\u201018\u201051\u2009991"],"award-info":[{"award-number":["P\u201018\u201051\u2009991"]}],"id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>Mycophenolic acid (MPA) is an immunosuppressive drug commonly used for prophylaxis of graft rejection in solid organ transplant recipients. The main concern with the prolonged use of immunosuppressive drugs is the risk of developing cancer. However, it remains unclear whether the immunosuppressive regimens containing MPA confer an increased degree of cancer risk. The present study aimed to determine the association between MPA exposure and the incidence of cancer in solid organ transplant recipients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search was performed on the PubMed, EMBASE and Cochrane Library databases. Relevant articles that had findings on the incidence (or event) of cancer in cohorts with and without MPA exposure were retrieved for data extraction. A meta\u2010analysis was conducted by means of the random\u2010effects model, and the relative risk (RR) and its 95% confidence interval (95% CI) were used as a summary effect measure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 39 studies were eligible for inclusion, with 32 studies that enabled meta\u2010analysis. MPA exposure was significantly associated with a lower risk of cancer when compared to azathioprine exposure (RR\u2009=\u20090.66, 95% CI\u2009=\u20090.53\u20100.81, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.001) or no exposure to any additional treatments (RR\u2009=\u20090.85, 95% CI\u2009=\u20090.73\u20100.99, <jats:italic>P<\/jats:italic>\u2009=\u2009.04). There was no significant difference in cancer risk for the comparison between MPA exposure and mammalian target of rapamycin (mTOR) inhibitor exposure (RR\u2009=\u20091.54, 95% CI\u2009=\u20090.96\u20102.46, <jats:italic>P<\/jats:italic>\u2009=\u2009.07).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MPA exposure was not associated with an increased risk of cancer and may even be associated with a lower risk of cancer when compared to azathioprine or no treatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.14979","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T03:55:18Z","timestamp":1625802918000},"page":"476-489","source":"Crossref","is-referenced-by-count":34,"title":["Mycophenolic acid and cancer risk in solid organ transplant recipients: Systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"88","author":[{"given":"Pannaphak","family":"Hirunsatitpron","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Chiang Mai University  Thailand"},{"name":"Master's Degree Program in Pharmacology, Faculty of Medicine Chiang Mai University  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutthiya","family":"Hanprasertpong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Chiang Mai University  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajohnsak","family":"Noppakun","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Faculty of Medicine Chiang Mai University  Thailand"},{"name":"Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy Chiang Mai University  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumnoensun","family":"Pruksakorn","sequence":"additional","affiliation":[{"name":"Musculoskeletal Science and Translational Research Center, Faculty of Medicine Chiang Mai University  Thailand"},{"name":"Omics Center for Health Science, Faculty of Medicine Chiang Mai University  Thailand"},{"name":"Biomedical Engineering Institute Chiang Mai University  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supanimit","family":"Teekachunhatean","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Chiang Mai University  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-597X","authenticated-orcid":false,"given":"Nut","family":"Koonrungsesomboon","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine Chiang Mai University  Thailand"},{"name":"Musculoskeletal Science and Translational Research Center, Faculty of Medicine Chiang Mai University  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200115010-00004"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e328358000c"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2020.101681"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(00)00188-0"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067411"},{"issue":"1","key":"e_1_2_9_7_1","first-page":"139","article-title":"Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection","volume":"5","author":"Dalal P","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(02)00612-1"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61050-2"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0022-6"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767080-00006"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm085"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2004.11.010"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.013"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/11319260-000000000-00000"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02386.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1039\/b313199h"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314617.118"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.02.011"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/35074122"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.7182\/pit2015826"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dsu.12028"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(03)00186-4"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000179639.98338.39"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13596"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01125.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581810374654"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"e_1_2_9_29_1","first-page":"1","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","journal-title":"BMJ"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2016.22.10.1107"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533446"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1081\/BIP-200067915"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780140406"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.883979"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000100826.58738.2B"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31825475a3"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00271.x"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.06.031"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2005.00338.x"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2018.07.011"},{"issue":"4","key":"e_1_2_9_44_1","first-page":"227","article-title":"Posttransplant lymphoproliferative disorders in kidney transplant recipients: an Iranian multicenter experience","volume":"2","author":"Einollahi B","year":"2008","journal-title":"Iran J Kidney Dis"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.881994"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2005.02.002"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199908150-00011"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00504.x"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000169035.10572.c6"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7089482"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199604150-00008"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199808270-00016"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01117.x"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.11.008"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2019.05.013"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000164352.65613.24"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199806150-00007"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200003150-00035"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2006.06.010"},{"key":"e_1_2_9_60_1","first-page":"776","article-title":"Evaluation of renal function after a transition to everolimus or mycophenolate mofetil in liver transplant recipients","volume":"17","author":"Perez C","year":"2017","journal-title":"Am J Transplant"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006101153"},{"key":"e_1_2_9_62_1","first-page":"93","article-title":"Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy","volume":"9","author":"Rivinius R","year":"2015","journal-title":"Drug des Devel Ther"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.07.072"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31823ae7db"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001520"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31822d880d"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200104270-00014"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2000.14041002.x"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01063.x"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.03.012"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2015.12.071"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.881859"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13863"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1114233"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0553-2"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.01.031"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2008.01.008"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022137"},{"key":"e_1_2_9_79_1","first-page":"93","article-title":"Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy","volume":"9","author":"Rivinius R","year":"2014","journal-title":"Drug des Devel Ther"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000253756.69243.65"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910570421"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091346"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/423401"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173580"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0747"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-012-9822-x"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06751-2"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2062"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0754-1"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030755"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00396-1"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10010018"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms13021886"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.01.030"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1159\/000107356"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrmr.2016.09.001"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v2.i4.27"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199812270-00002"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.7.2581"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14979","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14979","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:13:38Z","timestamp":1692850418000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1111\/bcp.14979"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14979","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]}}}